U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07809672) titled 'Efficacy and Safety of Stereotactic Body Radiation Therapy for Spinal Metastases With Bilsky Grade 1c-3' on Sept. 03.

Brief Summary: This prospective, multicenter, single-arm phase II clinical trial is designed to enroll patients with spinal metastases classified as Bilsky grade 1c-3 who will receive stereotactic body radiation therapy (SBRT). The objective of this study is to assess the efficacy and safety of SBRT in the treatment of spinal metastases with epidural spinal cord compression (Bilsky grade 1c-3).

Study Start Date: Sept. 03

Study Type: INTERVENTIONAL

Condition: Stereotactic Body Radiation Therapy (SBRT) Spinal Meta...